Analysts Giddy About InterMune (ITMN) On Expected Pirfenidone Approval
Tweet Send to a Friend
Shares of InterMune (Nasdaq: ITMN) have surged 63% today after an FDA advisory panel voted 9-3 to recommend approval of ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
